| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/20/2010 | CA2425820C Convection-enhanced delivery of aav vectors |
| 07/20/2010 | CA2421339C Novel polypeptides and nucleic acids encoding the same |
| 07/20/2010 | CA2406077C Formulation for the prevention of cardiovascular disease |
| 07/20/2010 | CA2366694C Process for the preparation of cyclo (asp-dphe-nmeval-arg-gly) |
| 07/20/2010 | CA2309679C Method of identifying binding site domains that retain the capacity of binding to an epitope |
| 07/20/2010 | CA2289980C Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays |
| 07/20/2010 | CA2288983C Covalently linked n,o-carboxymethylchitosan and uses thereof |
| 07/20/2010 | CA2271249C Macromolecular neuraminidase-binding compounds |
| 07/20/2010 | CA2246733C Use of a pharmaceutical composition comprising an appetite-suppressing peptide |
| 07/20/2010 | CA2197235C Adenovirus comprising a gene coding for glutathion peroxidase |
| 07/20/2010 | CA2191063C Dna encoding glutamate gated chloride channels |
| 07/20/2010 | CA2105449C An interferon-.alpha./.beta. binding protein, its preparation and pharmaceutical compositions containing it |
| 07/15/2010 | WO2010081131A1 Compositions and methods for diagnosis and treatment of type 2 diabetes |
| 07/15/2010 | WO2010081112A1 Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22 |
| 07/15/2010 | WO2010081091A2 Therapeutic compositions for treatment of corneal disorders |
| 07/15/2010 | WO2010081012A2 Disease control with tick phospholipase a2 |
| 07/15/2010 | WO2010080976A1 Insulin therapies for the treatment of diabetes, diabetes related ailments, and/or diseases or conditions other than diabetes or diabetes related ailments |
| 07/15/2010 | WO2010080964A1 Method for treating hyperglycemia with glp-1 |
| 07/15/2010 | WO2010080915A1 Compositions for enhancing nail growth |
| 07/15/2010 | WO2010080913A1 Cyclosporine compositions for enhancing nail growth |
| 07/15/2010 | WO2010080878A1 Combination of a cyclosporine derivative and nucleosides for treating hcv |
| 07/15/2010 | WO2010080874A1 Cyclosporine derivative for use in the treatment of hcv and hiv infection |
| 07/15/2010 | WO2010080836A2 Antibacterial and antifungal peptides |
| 07/15/2010 | WO2010080833A1 Treatment of mucositis with kallikrein inhibitors |
| 07/15/2010 | WO2010080819A1 Targeted antimicrobial moieties |
| 07/15/2010 | WO2010080769A2 Chemotherapeutic methods and compositions |
| 07/15/2010 | WO2010080607A1 Yl-based insulin-like growth factors exhibiting high activity at the insulin receptor |
| 07/15/2010 | WO2010080605A1 Dipeptide linked medicinal agents |
| 07/15/2010 | WO2010080578A1 Biologically active proteins activatable by peptidase |
| 07/15/2010 | WO2010080528A1 Hepatitis c virus combination therapy |
| 07/15/2010 | WO2010080506A1 Compositions and methods to prevent cancer with cupredoxins |
| 07/15/2010 | WO2010080188A2 Epitope targeted anthrax vaccine |
| 07/15/2010 | WO2010080124A2 Nkg2d-fc for immunotherapy |
| 07/15/2010 | WO2010079998A2 Use of hog, ras, and camp signal pathway genes for fungal infection treatment |
| 07/15/2010 | WO2010079811A1 Gene sensitive to diseases associated with intervertebral disc degeneration, and use thereof |
| 07/15/2010 | WO2010079511A2 Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof |
| 07/15/2010 | WO2010079362A1 Complex and production process |
| 07/15/2010 | WO2010079286A1 Novel anti-ageing peptides, and cosmetic and/or pharmaceutical composition containing same |
| 07/15/2010 | WO2010079285A1 Novel anti-ageing peptides and cosmetic and/or pharmaceutical composition containing same |
| 07/15/2010 | WO2010079284A1 Novel anti-ageing peptides and cosmetic and/or pharmaceutical composition containing same |
| 07/15/2010 | WO2010079156A1 Non-invasive tools for detecting vulnerable atherosclerotic plaques |
| 07/15/2010 | WO2010079063A2 Modulators of the cx3cr1 receptor and therapeutic uses thereof |
| 07/15/2010 | WO2010078916A1 Immunocytokines for tumour therapy with chemotherapeutic agents |
| 07/15/2010 | WO2010078911A1 Antiviral patch |
| 07/15/2010 | WO2010078842A1 Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases |
| 07/15/2010 | WO2010078648A1 Treatment of soft tissue injury using hyaluronic acid and botulinum toxin |
| 07/15/2010 | WO2010078624A1 Materials and methods for the treatment of hypertension |
| 07/15/2010 | WO2010053550A3 Cxcr4 receptor compounds |
| 07/15/2010 | WO2010053547A3 Cxcr5 receptor compounds |
| 07/15/2010 | WO2010048941A3 N-terminally modified tetrapeptide derivatives having a c-terminal arginine mimetic |
| 07/15/2010 | WO2010048610A3 Compositions and methods for promoting bone formation |
| 07/15/2010 | WO2010036936A9 Use of pituitary adenylate cyclase-activating polypeptide (pacap) and pacap analogs as adjunctive treatments with anticancer agents |
| 07/15/2010 | WO2010033879A3 Inhibiting interaction between hif-1a and p300/cbp with hydrogen bond surrogate-based helices |
| 07/15/2010 | WO2010023207A3 Antimicrobial agents |
| 07/15/2010 | WO2010018731A3 A mammalian rna dependent rna polymerase |
| 07/15/2010 | WO2010003520A3 Anti-tumor immunotherapy |
| 07/15/2010 | WO2009158412A3 Sustained delivery of exenatide and other polypeptides |
| 07/15/2010 | WO2009150470A3 Suppression of cancers |
| 07/15/2010 | WO2009150469A3 Suppression of neuroendocrine diseases |
| 07/15/2010 | WO2009149021A3 Xbp1, cd138, and cs1 peptides |
| 07/15/2010 | WO2009135494A3 Alpha-lactalbumin composition for the treatment of actinic keratosis |
| 07/15/2010 | WO2009130181A3 Dry transglutaminase composition |
| 07/15/2010 | WO2009105624A3 Simultaneous delivery of receptors and/or co-receptors for growth factor stability and activity |
| 07/15/2010 | WO2009103821A3 Regulators of pb1-f2 activity for treating virus infections |
| 07/15/2010 | WO2009033282A8 Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects |
| 07/15/2010 | US20100179646 Glucose oxidase techniques |
| 07/15/2010 | US20100179515 Tissue roll scaffolds |
| 07/15/2010 | US20100179304 Somatostatin-Dopamine Chimeric analogs |
| 07/15/2010 | US20100179212 Pharmaceutical composition which improves in vivo gene transfer |
| 07/15/2010 | US20100179096 Methods of treating fibrosing diseases by induction of immune tolerance |
| 07/15/2010 | US20100179095 Use of folates for producing a preparation suitable for preventing and treating inflammation and diseases associated with inflammation, especially for influencing the inflammation markers crp and saa |
| 07/15/2010 | US20100179094 Bispecific egfr/igfir binding molecules |
| 07/15/2010 | US20100179093 Neoropeptide-2-Receptor (Y-2R) Agonists |
| 07/15/2010 | US20100179092 Human complement c3 derivatives with cobra venom factor-like function |
| 07/15/2010 | US20100179091 Treatment of Conditions Related to Shock |
| 07/15/2010 | US20100179090 Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein |
| 07/15/2010 | US20100179089 Compositions and Methods to Manage the Inflammatory Basis of Chronic Disease Conditions and Maintain an Optimal Immune Response in Elderly |
| 07/15/2010 | US20100178355 Method for in situ solidification of blood-polymer compositions for regenerative medicine and cartilage repair applications |
| 07/15/2010 | US20100178346 Disc augmentation with hyaluronic acid |
| 07/15/2010 | US20100178344 Extended-Release Composition Comprising a Somatostatin Derivative in Microparticles |
| 07/15/2010 | US20100178337 Composition comprising an active agent with low aqueous solubility |
| 07/15/2010 | US20100178331 Preparation for transnasal application |
| 07/15/2010 | US20100178324 Composition and method for the treatment of diseases affected by apoptosis |
| 07/15/2010 | US20100178320 New medical products |
| 07/15/2010 | US20100178314 Freeze-dried fibrin matrices and methods for preparation thereof |
| 07/15/2010 | US20100178313 Implantable Degradable Biopolymer Fiber Devices |
| 07/15/2010 | US20100178304 Method for silk fibroin gelation using sonication |
| 07/15/2010 | US20100178297 Means and methods for the recruitment and identification of stem cells |
| 07/15/2010 | US20100178288 Use of aphanamixis polystacha extracts or fractions against 5-lipoxygenase mediated diseases |
| 07/15/2010 | US20100178287 Use of coagulation proteins to lyse clots |
| 07/15/2010 | US20100178285 Synergistic anthelmintic composition |
| 07/15/2010 | US20100178284 Composition for the Skin, Specifically for Inhibiting Ingrown Hair |
| 07/15/2010 | US20100178283 Hypoxia related genes and proteins for the treatment and diagnosis of pregnancy related complications |
| 07/15/2010 | US20100178282 Compounds and methods for the diagnosis and treatment of amyloid associated diseases |
| 07/15/2010 | US20100178280 Use of sirt7 for treating age-related diseases |
| 07/15/2010 | US20100178272 Structure and use of 5'phosphate oligonucleotides |
| 07/15/2010 | US20100178271 Combination Therapy |
| 07/15/2010 | US20100178251 Dual-Sensitizer-Containing Luminescent Compounds, Conjugates, and Uses Thereof |
| 07/15/2010 | US20100178250 Method of Local Delivery of Bioactive and Diagnostic Agents Using Magnetizable Bone Cement |
| 07/15/2010 | US20100178243 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |